Comments
EU agency backs Novartis' Votubia for kidney tumors
22.09.2012. | ZURICH (Reuters) - European regulators on Friday recommended approval of a Novartis' drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC)....